Drug-related preference in cocaine addiction extends to images

Key points
- When given a choice between viewing pictures of cocaine and a variety of other images, cocaine addicted individuals, as compared to healthy, non-addicted research subjects, show a clear preference for the drug-related images.
- One of ten national laboratories overseen and primarily funded by the Office of Science of the U.S.
- "This behavioral study demonstrates for the first time that drug-related choice in cocaine addiction extends to abstract, non-pharmacological stimuli, facilitating the study of choice behavior in addiction without using actual cocaine," Moeller said.
- In the first task of the experiment, both healthy control subjects and cocaine-addicted individuals digitally selected one of four face-down card decks and could select a card again from the same deck or switch decks.
When given a choice between viewing pictures of cocaine and a variety of other images, cocaine addicted individuals, as compared to healthy, non-addicted research subjects, show a clear preference for the drug-related images. Findings from this study, which was conducted at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, will be presented at the Society for Neuroscience annual meeting in Washington D.C. on Sunday, November 16, 2008, at 2:30 p.m. Eastern Time, by Scott Moeller, a psychology graduate student at the University of Michigan who worked with the Brookhaven Lab Neuropsychoimaging group (director, Rita Goldstein) on this research.
"This behavioral study demonstrates for the first time that drug-related choice in cocaine addiction extends to abstract, non-pharmacological stimuli, facilitating the study of choice behavior in addiction without using actual cocaine," Moeller said. Previously, scientists have had to administer the actual drug (cocaine), or drugs that are pharmacologically similar to cocaine, to test its effects on brain and behavioral functions. Now, the tasks developed by Moeller while training with Goldstein's team could help clinicians monitor choice behavior — for example, to follow the effectiveness of treatment — in addicted individuals who are currently abstaining from drugs.
In the first task of the experiment, both healthy control subjects and cocaine-addicted individuals digitally selected one of four face-down card decks and could select a card again from the same deck or switch decks. Unknown to the subjects, each deck contained mostly one image type: cocaine-related images, pleasant images, unpleasant images, or neutral ones. This test of choice is considered implicit because subjects were not necessarily aware of their tendency to choose one type of image over the others. In the second, explicit choice task, subjects repeatedly selected between two side-by-side, face-up images taken from the four decks.
On both tasks, the cocaine-addicted individuals chose the cocaine-related images more than the healthy controls, who showed clear aversion to these images. In addition, on the implicit task, healthy control subjects chose pleasant images more than the cocaine-addicted subjects.
Interestingly, cocaine-addicted individuals' self-reported ratings of how pleasant they thought a picture was did not fully explain these results, nor were these ratings entirely consistent with their choice behavior. For example, while cocaine-addicted individuals rated pleasant images as more pleasant than the cocaine-related images, at the group level they still chose from these two picture categories at the same rates on both tasks. This suggests that drug-addicted individuals may not be fully aware of their own choice behavior or that drug choice in addicted individuals may not be fully driven by the pleasure or reward they get from the drug, as is frequently assumed.
Further, the cocaine-addicted individuals with the greater preference for cocaine-related images over pleasant ones had used cocaine more frequently in the previous month. This finding suggests these tasks could serve as objective measures of the severity of drug use (which, to date, has been measured primarily by self-report).
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsTherapy Free of Side Effects of Other HCV Drugs
An investigational protease inhibitor (PI) led to viral cures in about four out of five hepatitis C virus (HCV) patients, a researcher reported here. In a phase III study, either of two doses of faldaprevir combined…
26 April 2013
NewsGenes reveal which patients will benefit from scleroderma drug
Systemic sclerosis, also known as scleroderma, is a rare autoimmune connective tissue disorder that's difficult to treat. However, thanks to new research at Northwestern University Feinberg School of Medicine and…
11 April 2013
NewsThe Future of Nicotine Addiction: When Smokers Become Vapers
The nation's tobacco industry is facing one monumental impediment to future growth: a shrinking (and dying) customer base of cigarette smokers. Business 101 suggests three strategies to strengthen future sales and…
2 April 2013
